Anti-Bevacizumab Antibody (AY10) (MALS verified, recommended for PK/PD)
A recombinant humanized monoclonal IgG1 antibody that binds to and inhibits the biologic activity of human vascular endothelial growth factor (VEGF) . Bevacizumab contains human framework regions and the complementarity-determining regions of a murine antibody that binds to VEGF. Bevacizumab is produced in a Chinese Hamster Ovary mammalian cell expression system in a nutrient medium containing the antibiotic gentamicin and has a molecular weight of approximately 149 kilodaltons.
Product Specifications
Background
CAS Number
9007-83-4
Host
Hybridoma
Origin Species
Mouse
Target
Bevacizumab
Conjugation
Unconjugated
Stability
Purity
0.95
Bioactivity
Immobilized Bevacizumab at 1 μg/mL (100 μL/well) can bind Anti-Bevacizumab Antibody (AY10) (Cat. No. BEB-Y10) with a linear range of 0.39-25 ng/mL.
Format
Powder
Buffer
Tris with Glycine, Arginine and NaCl, pH7.5
Additives
Trehalose
Additionnal Information
Please see 'Shipping-and-Payments' sheet. Website: https://www.acrobiosystems.com/support/shipping-and-payments
Shipping Conditions
RT
Storage Conditions
-20°C
Package Size
100ug*1
Host or Source
Hybridoma
Species
Mouse
Preservative
Trehalose
Explore Other Products
Browse additional items from our catalog
LMAN2L (VIP36-like Protein, Lectin mannose-Binding 2-like, LMAN2-like Protein, LMAN2L, VIPL) (PE)
LMAN2L (VIP36-like Protein, Lectin mannose-Binding 2-like, LMAN2-like Protein, LMAN2L, VIPL) (PE)
AKR7L (Aflatoxin B1 Aldehyde Reductase Member 4, 1, AFB1 Aldehyde Reductase 3, AFB1-AR 3, Aldoketoreductase 7-like, AKR7L, AFAR3, AKR7A4) (MaxLight 490) discontinued